These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9217738)

  • 1. Are Hib booster vaccinations redundant?
    Böhm O; von Kries R
    Lancet; 1997 Jul; 350(9070):68. PubMed ID: 9217738
    [No Abstract]   [Full Text] [Related]  

  • 2. Are Hib booster vaccinations redundant?
    Heath PT; Booy R; Slack MP; Moxon ER; Fogarty J
    Lancet; 1997 Sep; 350(9080):817. PubMed ID: 9298035
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of Hib vaccine.
    Teare EL; Fairley CK; White J; Begg NT
    Lancet; 1994 Sep; 344(8925):828-9. PubMed ID: 7916111
    [No Abstract]   [Full Text] [Related]  

  • 4. Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):673-4. PubMed ID: 19553904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(33):1069-72. PubMed ID: 20798669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
    Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
    Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hib booster dose for children ages 12-15 months reinstated.
    Mich Med; 2009; 108(5):19. PubMed ID: 19999857
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.
    Garcia S; Lagos R; Muñoz A; Picón T; Rosa R; Alfonso A; Abriata G; Gentile A; Romanin V; Regueira M; Chiavetta L; Agudelo CI; Castañeda E; De la Hoz F; Higuera AB; Arce P; Cohen AL; Verani J; Zuber P; Gabastou JM; Pastor D; Flannery B; Andrus J
    Vaccine; 2012 Jan; 30(2):486-92. PubMed ID: 22085550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hib immunisation catch up programme in North East Thames.
    O'Brien H
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R17-8. PubMed ID: 7511460
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.
    Kemmeren JM; Timmer SS; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(26):4373-7. PubMed ID: 21514347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
    Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
    Mangtani P; Mulholland K; Madhi SA; Edmond K; O'Loughlin R; Hajjeh R
    Vaccine; 2010 Feb; 28(7):1677-83. PubMed ID: 20034606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hib returns.
    Edwards A
    Minn Med; 2009 Mar; 92(3):35-6. PubMed ID: 19400384
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia.
    Cimaz R; Mensi C; D'Angelo E; Fantola E; Milone V; Biasio LR; Carnelli V; Zanetti AR
    J Infect Dis; 2001 Jun; 183(12):1819-21. PubMed ID: 11372038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Merino JM; Moro M; Navarro ML; Espín J; Omeñaca F; García-Sicilia J; Moreno-Pérez D; Ruiz-Contreras J; Centeno F; Barrio F; Cabanillas L; Muro M; Esporrin C; De Torres MJ; Caubet M; Boutriau D; Miller JM; Mesaros N
    Pediatr Infect Dis J; 2012 Oct; 31(10):1074-7. PubMed ID: 22828645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
    Ladhani S; Slack MP; Heys M; White J; Ramsay ME
    Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.